Travel Guard Health Advisory

Ebola Virus Disease

Recent reports from the media and public health authorities have highlighted cases of Ebola virus disease (EVD) in parts of Africa. Ebola is a serious but relatively rare infectious disease that occurs primarily in certain regions of sub-Saharan Africa. Outbreaks can occur sporadically and are closely monitored by international health authorities, including the World Health Organization (WHO).

Please find below some useful information regarding this situation.

What is Ebola virus disease (EVD)?

Ebola virus disease is a severe illness caused by infection with viruses of the genus Ebolavirus. It can affect humans and other primates.

EVD is a serious condition with a high case fatality rate, particularly in the absence of supportive medical care. However, outcomes have improved significantly with early diagnosis, supportive treatment, and the use of vaccines and therapeutics in outbreak settings.

What strain of Ebola is involved?

Several different species (strains) of Ebola virus have been identified. The most common strains associated with outbreaks include:

  • Zaire ebolavirus – Historically associated with the majority of large outbreaks and higher mortality rates.
  • Sudan ebolavirus – Responsible for several outbreaks in East Africa.
  • Bundibugyo ebolavirus – Associated with smaller outbreaks.

The current outbreak in the Democratic Republic of the Congo (DRC) has been identified as Bundibugyo virus disease (BVD), which is caused by the Bundibugyo ebolavirus species, one of the recognized Ebola viruses. This strain was first identified in Uganda in 2007 and has caused a limited number of outbreaks compared with the more common Zaire ebolavirus.

According to the World Health Organization (WHO), the current outbreak was declared by the DRC Ministry of Health on May 15, 2026, and is centered in the northeastern part of the country, particularly within Ituri Province, with transmission reported in the health zones of Mongbwalu, Rwampara and Bunia. Cases have also been reported in parts of North Kivu and South Kivu provinces. Imported cases linked to travel from DRC have been identified in neighboring Uganda.

The Bundibugyo strain differs from the Zaire strain because there is currently no licensed vaccine or specific antiviral treatment approved for routine use against it. As a result, outbreak control relies heavily on early detection, isolation of cases, contact tracing, infection prevention and control measures, safe burial practices, and community engagement.

WHO has noted that the outbreak is occurring in a complex environment affected by population movement, cross-border trade, humanitarian challenges, and insecurity, all of which can make outbreak control more difficult. Despite these challenges, international and national response teams are actively working to contain transmission and strengthen surveillance across affected areas.

Why does this matter for travelers?

Although the outbreak has attracted significant international attention, transmission remains concentrated within affected communities and healthcare settings in specific regions of eastern DRC. The risk for most international travelers remains low, particularly for those who are not working in healthcare settings or having direct contact with infected individuals or their bodily fluids. WHO does not currently recommend general travel or trade restrictions related to the outbreak.

How does Ebola spread?

Ebola spreads through direct contact with:

  • Blood or bodily fluids (such as saliva, vomit, urine, or feces) of an infected person
  • Contaminated objects (e.g., needles, medical equipment)
  • Infected animals (such as fruit bats or non-human primates)
  • The body of a person who has died from Ebola.

Transmission occurs when the virus enters the body through broken skin or mucous membranes (eyes, nose, or mouth).

Ebola does not spread through the air, water, or food in the same way as respiratory illnesses.

What are the symptoms of Ebola?

Symptoms usually begin suddenly and may include:

  • Fever
  • Severe headache
  • Muscle pain
  • Fatigue or weakness
  • Sore throat

As the illness progresses, symptoms may include:

  • Vomiting and diarrhea
  • Rash
  • Abdominal pain
  • Unexplained bleeding or bruising (in some cases)

Symptoms typically appear between two and 21 days after exposure.

Who may be at higher risk?

The risk of Ebola infection is higher for:

  • Healthcare workers caring for infected patients without appropriate protective measures.
  • Family members or close contacts with infected individuals
  • People participating in burial practices involving direct contact with the deceased.
  • Individuals handling infected animals or bushmeat.

Travelers who do not have direct exposure to these risk factors are at very low risk.

How can I protect myself while traveling?

General precautions include:

  • Avoid contact with blood or bodily fluids of any person.
  • Avoid contact with individuals who are unwell with compatible symptoms.
  • Avoid handling animals such as bats or primates and avoid consumption of bushmeat.
  • Practice good hand hygiene (frequent handwashing or use of alcohol-based sanitizer)
  • Follow local public health advice.

If traveling to areas where an outbreak is occurring, additional guidance from health authorities should be followed.

What should I do if I develop symptoms?

If you develop symptoms such as fever, weakness, or gastrointestinal illness within 21 days of travel to an affected area, you should:

  • Seek medical attention immediately.
  • Inform the healthcare provider about your travel history.
  • Avoid close contact with others until assessed.

Early medical care improves outcomes and helps prevent further transmission.

Is testing available?

Testing for Ebola is available in specialized laboratories and is coordinated through public health systems. Testing is recommended for individuals who have compatible symptoms and a history of possible exposure. It is not routinely required for asymptomatic travelers.

Is there a vaccine?

Vaccines against Ebola are available and have been used effectively in outbreak settings, particularly for people at high risk such as healthcare workers and close contacts of confirmed cases. However, vaccine availability depends on the strain involved. As previously mentioned, there is no available vaccine for the Bundibugyo strain and outbreak control relies on methods outlined above. Vaccination is not routinely recommended for most travelers.

Should I continue traveling?

For most travelers, Ebola does not significantly affect travel plans. The risk remains very low outside of specific outbreak areas.

The current Ebola outbreak is concentrated primarily in parts of Ituri Province in northeastern DRC, with cases also reported in some areas of North Kivu and South Kivu. These areas are geographically distant from many other parts of the country and from most international travel routes.

The World Health Organization (WHO) currently advises against travel or trade restrictions related to the outbreak and does not recommend border closures. WHO advises that travelers can continue to travel provided they follow public health advice and avoid exposure to individuals with suspected or confirmed Ebola infection.

Questions?

Call us at: 800-826-5248

Find us on Facebook Meta    Travel Guard on LinkedIn    Travel Guard's You Tube Channel    Find us on Instagram

Travel Guard UStiA member      Travel Guard BBB accreditation      IGLTA-logo

Copyright © 2026, Travel Guard. Non insurance services are provided by Travel Guard.
Terms of Use   |   Privacy Policy   |  Accessibility Statement   |   Our Underwriter  |   Do Not Sell or Share My Personal Information  |  About Our Ads  |  Sitemap |

 

Coverage available to residents of U.S. states and the District of Columbia only. This plan provides insurance coverage that only applies during the covered trip. Similar travel insurance coverage, offered by Travel Guard or another insurance provider, may be available through a variety of other sources, but may be subject to different terms and conditions (i.e. benefits, limits, exclusions, etc.). You may wish to compare the terms and conditions of this policy with those of your existing life, health, home and automobile insurance policies, as well as any other coverage which you may already have or is available to you, including through other insurers, as a member of an organization, or through your credit card program(s). If you have any questions about your current coverage, call your insurer or insurance agent or broker. Coverage is offered by Travel Guard Group, Inc. (Travel Guard). California lic. no.0B93606, 3300 Business Park Drive, Stevens Point, WI 54482, www.travelguard.com. CA DOI toll free number: 800-927-HELP. This is only a brief description of the coverage(s) available. The Policy will contain reductions, limitations, exclusions and termination provisions. Insurance may be underwritten by American Zurich Insurance Company, a New York company (NAIC No. 40142), Zurich American Insurance Company, an Illinois company (NAIC No. 16535), each having its principal place of business at 1299 Zurich Way, Schaumburg, IL 60196, or National Union Fire Insurance Company of Pittsburgh, Pa. (NAIC No. 19445), a Pennsylvania insurance company, having its principal place of business at 1271 Avenue of the Americas, 37th FL, New York, NY 10020-1304. Please review the Plan offered to or purchased by you to confirm the underwriting insurer for your specific policy of insurance. Coverage may not be available in all states. Travel assistance services provided by Travel Guard.